United Therapeutics
UTHR
$223.93
Share price
1.48%
Change (1 day)
-2.01%
Change (1 year)
Categories
Operating Margin for United Therapeutics (UTHR)
Operating Margin as of September 2023 (TTM): 49.09%
According to United Therapeutics's latest financial reports and stock price the company's current Operating Margin is 49.09%. At the end of 2022 the company had an Operating Margin of 49.09%.
Operating Margin history for United Therapeutics from 2002 to 2001
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 49.09% | 39.33% |
| 2021 | 35.24% | -18.19% |
| 2020 | 43.07% | -478.21% |
| 2019 | -11.39% | -124.43% |
| 2018 | 46.62% | 4.53% |
| 2017 | 44.60% | -32.74% |
| 2016 | 66.31% | -6.94% |
| 2015 | 71.26% | 74.82% |
| 2014 | 40.76% | 63.23% |
| 2013 | 24.97% | -48.09% |
| 2012 | 48.10% | 19.52% |
| 2011 | 40.25% | 64.39% |
| 2010 | 24.48% | 382.51% |
| 2009 | 5.07% | -119.76% |
| 2008 | -25.68% | -426.7% |
| 2007 | 7.86% | -68.55% |
| 2006 | 25.00% | -39.02% |
| 2005 | 41.00% | 95.29% |
| 2004 | 20.99% | -212.33% |
| 2003 | -18.69% | -76.2% |
| 2002 | -78.52% | -87.93% |
| 2001 | -650.55% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | -29.50% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -49.77% | 🇺🇸 USA |
 Baxter BAX | -19.01% | -138.72% | 🇺🇸 USA |
 Gilead Sciences GILD | 26.84% | -45.32% | 🇺🇸 USA |
 Cardinal Health CAH | -0.42% | -100.86% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -54.08% | 🇬🇧 UK |
 Cytokinetics
CYTK | -5,422.18% | -11,145.39% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -20.53% | -141.82% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.